Ignite Creation Date:
2024-05-05 @ 11:48 AM
Last Modification Date:
2024-10-26 @ 9:13 AM
Study NCT ID:
NCT00130689
Status:
COMPLETED
Last Update Posted:
2015-05-14
First Post:
2005-08-15
Brief Title:
Use of Cetuximab for Unresectable or Metastatic Esophageal and Gastric Cancer
Sponsor:
Dana-Farber Cancer Institute
Organization:
Dana-Farber Cancer Institute